Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Protonix	O
/	O
iv	O
contrast	O
/	O
Iodinated	O
Contrast	O
Media	O
-	O
IV	O
Dye	O
Attending:	O
___.	O
Chief	O
Complaint:	O
dyspnea	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
female	O
history	O
of	O
diabetes,	O
hypertension,	O
CKD.	O
presents	O
for	O
evaluation	O
of	O
dyspnea.	O
Patient	O
reports	O
gradually	O
worsening	O
dyspnea	O
over	O
past	O
three	O
months	O
in	O
the	O
setting	O
of	O
worsening	O
CKD.	O
According	O
to	O
her	O
granddaughter,	O
her	O
PCP	O
___.	O
___	O
has	O
been	O
adjusting	O
her	O
home	O
furosemide	O
dosing	O
with	O
relatively	O
good	O
effect.	O
However,	O
this	O
morning	O
she	O
woke	O
up	O
and	O
became	O
very	O
dyspneic	O
when	O
she	O
went	O
to	O
stand	O
up	O
from	O
bed.	O
She	O
sat	O
back	O
down	O
for	O
several	O
minutes,	O
but	O
again	O
became	O
short	O
of	O
breath	O
when	O
she	O
went	O
to	O
stand.	O
The	O
patient	O
also	O
noted	O
a	O
"stabbing	O
pain"	O
under	O
her	O
L	O
breast	O
which	O
lasted	O
for	O
several	O
minutes	O
and	O
resolved	O
without	O
intervention.	O
She	O
then	O
called	O
EMS	O
and	O
was	O
brought	O
to	O
ED.	O
In	O
the	O
ED,	O
initial	O
vitals	O
were	O
T	O
98.7,	O
P	O
86,	O
BP	O
198/93,	O
RR	O
20,	O
O2	O
100%2L	O
NC.	O
CXR	O
showed	O
moderate	O
pulmonary	O
edema	O
and	O
small	O
bilateral	O
pleural	O
effusions.	O
EKG	O
showed	O
sinus	O
rhythm	O
with	O
rate	O
of	O
80,	O
LVH	O
but	O
no	O
ischemic	O
changes.	O
Labs	O
revealed	O
Trop	O
0.06,	O
BNP	O
4672.	O
Creatinine	O
5.2,	O
baseline	O
unclear	O
as	O
creatinine	O
has	O
been	O
steadily	O
increasing	O
from	O
3.5	O
in	O
___.	O
Electrolytes	O
wnl,	O
Hb	O
8.6,	O
which	O
is	O
baseline.	O
Patient	O
given	O
home	O
Metoprolol	O
XL,	O
Amlodipine	O
in	O
ED,	O
plus	O
ASA	O
325	O
and	O
Furosemide	O
40mg	O
IV	O
in	O
ED	O
and	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
breathing	O
quickly	O
on	O
2L	O
NC,	O
but	O
does	O
not	O
appear	O
to	O
be	O
in	O
distress.	O
Reports	O
no	O
current	O
CP	O
or	O
SOB.	O
She	O
denies	O
CP	O
or	O
pressure	O
with	O
activity,	O
has	O
no	O
known	O
CAD.	O
Clean	O
coronaries	O
by	O
angiography	O
in	O
___	O
at	O
___,	O
no	O
history	O
of	O
cardiac	O
catheterization.	O
Denies	O
fevers,	O
chills,	O
abdominal	O
pain,	O
nausea	O
or	O
vomiting.	O
Reports	O
stable	O
leg	O
swelling	O
and	O
orthopnea.	O
Past	O
Medical	O
History:	O
-CHRONIC	O
KIDNEY	O
DISEASE	O
L	O
arm	O
A-V	O
graft	O
for	O
dialysis	O
access	O
for	O
stage	O
5	O
CKD	O
___	O
-DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
s/p	O
incision	O
___	O
-CARDIOVASCULAR	O
Nonspecific	O
ECG	O
changes	O
in	O
the	O
absence	O
of	O
anginal	O
type	O
symptoms	O
per	O
ETT	O
___.	O
Admitted	O
to	O
___	O
with	O
vertigo	O
and	O
new	O
left	O
bundle	O
branch	O
block	O
on	O
ECG	O
clean	O
coronaries	O
(lesions	O
<	O
23%	O
occlusions)	O
on	O
coronary	O
angiography	O
per	O
Dr	O
___	O
___	O
Cardiology	O
___.	O
-ANEMIA	O
Anemia	O
likely	O
secondary	O
to	O
renal	O
insufficiency,	O
sickle	O
trait.	O
-PULMONARY	O
Bibasilar	O
scarring,	O
biapical	O
pleural	O
thickening	O
___	O
25	O
mm	O
ring	O
shadow	O
?	O
bulla	O
or	O
cavity,	O
vascular	O
distortion	O
suggestive	O
of	O
COPD	O
on	O
CXR	O
___.	O
-S/P	O
CHOLECYSTECTOMY	O
___	O
TRANSIENT	O
JAUNDICE	O
WITH	O
PANCREATITIS:	O
LIKELY	O
SECONDARY	O
TO	O
PASSAGE	O
OF	O
GALLSTONE	O
___	O
-SICKLE	O
TRAIT	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
had	O
history	O
of	O
DM,	O
HTN	O
Physical	O
Exam:	O
Admission	O
Exam	O
==================	O
VS:	O
T	O
97.1,	O
BP	O
183/92,	O
P	O
73,	O
RR	O
20,	O
O2	O
95%	O
1L	O
GENERAL:	O
elderly	O
woman,	O
lying	O
in	O
bed,	O
breathing	O
quickly	O
on	O
2L	O
NC	O
but	O
in	O
NAD.	O
HEENT:	O
MMM,	O
o/p	O
clear	O
Neck:	O
supple,	O
JVP	O
elevated	O
to	O
10cm	O
CV:	O
RRR,	O
normal	O
S1,	O
S2.	O
___	O
holosystolic	O
murmur	O
best	O
heard	O
at	O
LUSB	O
Lungs:	O
Poor	O
air	O
movement,	O
crackles	O
midway	O
up	O
lungs	O
b/l	O
Abdomen:	O
soft,	O
NT/ND,	O
BS+	O
Ext:	O
WWP,	O
2+	O
peripheral	O
edema	O
to	O
the	O
knees	O
bilaterally	O
Neuro:	O
moving	O
all	O
extremities	O
grossly	O
Discharge	O
Exam	O
============	O
VS:	O
T	O
98.5,	O
BP	O
149/75(123-167/52-76),	O
P	O
73(69-75),	O
RR	O
18,	O
O2	O
100%	O
RA	O
Weight	O
77.7<-78.2<-79	O
kg	O
<-79.1<-80.9<-81.6	O
(81.5)	O
IN	O
1200/400+2	O
voids	O
GENERAL:	O
elderly	O
woman,	O
lying	O
in	O
bed,	O
breathing	O
comfortably	O
on	O
RA	O
HEENT:	O
MMM,	O
o/p	O
clear	O
Neck:	O
supple,	O
JVP	O
elevated	O
to	O
9cm	O
CV:	O
RRR,	O
normal	O
S1,	O
S2.	O
___	O
holosystolic	O
murmur	O
best	O
heard	O
at	O
LUSB	O
Lungs:	O
Poor	O
air	O
movement,	O
few	O
bibasilar	O
crackles.	O
Loud	O
inspiration	O
and	O
dull	O
expiration	O
Abdomen:	O
soft,	O
NT/ND,	O
BS+	O
Ext:	O
WWP,	O
trace	O
peripheral	O
edema	O
to	O
the	O
mid	O
shin.	O
Neuro:	O
moving	O
all	O
extremities	O
grossly	O
Pertinent	O
Results:	O
Admission	O
Labs	O
=================	O
___	O
10:00AM	O
BLOOD	O
WBC-4.0	O
RBC-3.11*	O
Hgb-8.6*	O
Hct-26.8*	O
MCV-86	O
MCH-27.7	O
MCHC-32.1	O
RDW-15.7*	O
RDWSD-49.3*	O
Plt	O
___	O
___	O
10:00AM	O
BLOOD	O
Neuts-52.5	O
___	O
Monos-8.3	O
Eos-3.3	O
Baso-0.3	O
Im	O
___	O
AbsNeut-2.10	O
AbsLymp-1.40	O
AbsMono-0.33	O
AbsEos-0.13	O
AbsBaso-0.01	O
___	O
10:00AM	O
BLOOD	O
___	O
PTT-26.0	O
___	O
___	O
10:00AM	O
BLOOD	O
Plt	O
___	O
___	O
10:00AM	O
BLOOD	O
Glucose-119*	O
UreaN-36*	O
Creat-5.2*	O
Na-145	O
K-4.6	O
Cl-107	O
HCO3-24	O
AnGap-19	O
___	O
10:00AM	O
BLOOD	O
CK(CPK)-148	O
___	O
05:05PM	O
BLOOD	O
CK(CPK)-121	O
___	O
10:00AM	O
BLOOD	O
CK-MB-2	O
proBNP-4672*	O
___	O
10:00AM	O
BLOOD	O
cTropnT-0.06*	O
___	O
05:05PM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.06*	O
___	O
05:05PM	O
BLOOD	O
Calcium-8.3*	O
Phos-5.4*	O
Mg-1.9	O
Imaging	O
========	O
ECG	O
___	O
Normal	O
sinus	O
rhythm.	O
Borderline	O
voltage	O
criteria	O
for	O
left	O
ventricular	O
hypertrophy	O
with	O
secondary	O
repolarization	O
abnormalities.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
there	O
is	O
no	O
significant	O
change.	O
Read	O
___.	O
Intervals	O
Axes	O
RatePRQRSQTQTc	O
(___)	O
___	O
___	O
CXR	O
___	O
FINDINGS:	O
There	O
is	O
pulmonary	O
vascular	O
engorgement,	O
with	O
mild	O
pulmonary	O
edema.	O
Note	O
is	O
made	O
of	O
small	O
bilateral	O
pleural	O
effusions	O
with	O
adjacent	O
atelectasis.	O
The	O
heart	O
is	O
enlarged,	O
which	O
appears	O
increased	O
from	O
the	O
prior.	O
No	O
pneumothorax.	O
IMPRESSION:	O
Mild	O
pulmonary	O
edema.	O
TTE	O
___	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
normal.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
Tissue	O
Doppler	O
imaging	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP>18mmHg).	O
The	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
with	O
normal	O
free	O
wall	O
contractility.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
There	O
is	O
mild	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
1.2-1.9cm2).	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	O
regurgitation.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
very	O
small	O
circumferential	O
pericardial	O
effusion	O
without	O
evidence	O
for	O
hemodynamic	O
compromise.	O
IMPRESSION:	O
Moderate	O
pulmonary	O
artery	O
hypertension.	O
Mild	O
right	O
ventricular	O
cavity	O
dilation	O
with	O
preserved	O
free	O
wall	O
motion.	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
preserved	O
regional	O
and	O
global	O
systolic	O
function.	O
Mild	O
aortic	O
valve	O
stenosis.	O
Increased	O
PCWP.	O
Very	O
small	O
circumferential	O
pericardial	O
effusion.	O
The	O
right	O
ventricular	O
cavity	O
dilation	O
with	O
pulmonary	O
artery	O
systolic	O
hypertension	O
raises	O
the	O
possibility	O
of	O
a	O
primary	O
pulmonary	O
process	O
(e.g.,	O
pulmonary	O
embolism,	O
COPD,	O
OSA,	O
etc.	O
CLINICAL	O
IMPLICATIONS:	O
The	O
patient	O
has	O
mild	O
aortic	O
valve	O
stenosis.	O
Based	O
on	O
___	O
ACC/AHA	O
Valvular	O
Heart	O
Disease	O
Guidelines,	O
a	O
follow-up	O
echocardiogram	O
is	O
suggested	O
in	O
___	O
years.	O
Discharge	O
Labs	O
===========	O
___	O
08:10AM	O
BLOOD	O
WBC-4.8	O
RBC-3.19*	O
Hgb-8.9*	O
Hct-28.0*	O
MCV-88	O
MCH-27.9	O
MCHC-31.8*	O
RDW-16.2*	O
RDWSD-51.8*	O
Plt	O
___	O
___	O
08:10AM	O
BLOOD	O
Plt	O
___	O
___	O
08:10AM	O
BLOOD	O
___	O
PTT-26.8	O
___	O
___	O
08:10AM	O
BLOOD	O
Glucose-128*	O
UreaN-63*	O
Creat-7.3*	O
Na-138	O
K-4.4	O
Cl-99	O
HCO3-24	O
AnGap-19	O
___	O
08:10AM	O
BLOOD	O
Calcium-9.0	O
Phos-5.7*	O
Mg-2.___	O
female	O
history	O
of	O
diabetes,	O
hypertension,	O
CKD.	O
presents	O
for	O
evaluation	O
of	O
dyspnea.	O
#	O
Acute	O
diastolic	O
heart	O
failure:	O
Patient	O
presented	O
with	O
gradual	O
worsening	O
DOE,	O
with	O
BNP	O
4672,	O
moderate	O
pulmonary	O
edema	O
and	O
evidence	O
of	O
volume	O
overload	O
on	O
exam.	O
Likely	O
precipitated	O
by	O
worsening	O
kidney	O
failure	O
and	O
hypertensive	O
urgency.	O
Repeat	O
TTE	O
revealed	O
preserved	O
EF	O
with	O
R	O
ventricular	O
dilatation,	O
mild	O
AS,	O
increased	O
wedge	O
and	O
moderate	O
pulmonary	O
HTN.	O
Patient	O
initially	O
required	O
___	O
NC,	O
but	O
was	O
weaned	O
off	O
oxygen	O
with	O
diuresis.	O
She	O
was	O
diuresed	O
to	O
euvolemia	O
with	O
Lasix	O
bolus/drip	O
with	O
Metolazone.	O
Creatinine	O
steadily	O
rose	O
in	O
the	O
setting	O
of	O
diuresis	O
and	O
was	O
7.3	O
at	O
discharge,	O
so	O
decision	O
was	O
made	O
to	O
discharge	O
patient	O
on	O
gentle	O
diuresis,	O
to	O
attempt	O
to	O
maintain	O
euvolemia,	O
but	O
not	O
worsen	O
kidney	O
function.	O
Patient's	O
Metoprolol	O
XL	O
was	O
discontinued	O
and	O
replaced	O
with	O
Labetalol	O
for	O
improved	O
blood	O
pressure	O
control.	O
Patient	O
discharged	O
on	O
Labetalol	O
and	O
Torsemide	O
20mg	O
every	O
other	O
day	O
with	O
close	O
Cardiology	O
follow	O
up.	O
#	O
Acute	O
on	O
chronic	O
Kidney	O
Disease:	O
Stage	O
5	O
CKD,	O
has	O
fistula	O
in	O
place,	O
but	O
has	O
not	O
yet	O
initiated	O
dialysis.	O
Creatinine	O
had	O
been	O
steadily	O
rising	O
since	O
early	O
this	O
year	O
and	O
was	O
5.2	O
on	O
admission.	O
Possible	O
component	O
of	O
cardio-renal,	O
as	O
patient	O
is	O
in	O
acute	O
heart	O
failure.	O
Renal	O
was	O
consulted,	O
but	O
recommended	O
attempting	O
to	O
diurese	O
patient	O
before	O
initiating	O
conversation	O
about	O
dialysis.	O
Patient	O
diuresed	O
well	O
with	O
IV	O
Lasix	O
bolus/drip	O
and	O
Metolazone,	O
but	O
Creatinine	O
continued	O
to	O
rise,	O
peaking	O
at	O
7.4.	O
Patient	O
continued	O
on	O
home	O
sodium	O
bicarbonate	O
and	O
calcitriol	O
and	O
was	O
started	O
on	O
Sevelamer	O
TID	O
with	O
meals	O
for	O
rising	O
phosphorus.	O
After	O
extensive	O
discussion	O
with	O
patient's	O
PCP,	O
outpatient	O
renal	O
provider	O
and	O
inpatient	O
renal	O
team,	O
decision	O
was	O
made	O
not	O
to	O
initiate	O
dialysis.	O
Patient	O
continued	O
to	O
put	O
out	O
urine	O
throughout	O
admission	O
and	O
showed	O
no	O
signs	O
of	O
uremia.	O
Electrolytes	O
remained	O
within	O
normal	O
limits.	O
Patient's	O
Creatinine	O
was	O
7.3	O
at	O
discharge.	O
She	O
will	O
have	O
repeat	O
labs	O
within	O
one	O
week	O
and	O
extremely	O
close	O
outpatient	O
renal	O
follow	O
up.	O
#Hypertensive	O
Urgency:	O
Patient's	O
blood	O
pressures	O
in	O
190-200	O
systolic	O
on	O
admission,	O
despite	O
home	O
medications.	O
Per	O
patient	O
records,	O
she	O
has	O
history	O
of	O
labile	O
blood	O
pressures.	O
Patient	O
was	O
continued	O
on	O
home	O
Amlodipine,	O
but	O
Metoprolol	O
XL	O
was	O
discontinued	O
and	O
she	O
was	O
started	O
on	O
Labetalol	O
200mg	O
TID.	O
Patient's	O
blood	O
pressures	O
improved	O
significantly	O
and	O
remained	O
within	O
target	O
range	O
throughout	O
admission.	O
Patient	O
discharged	O
on	O
Amlodipine	O
and	O
Labetalol	O
with	O
close	O
PCP	O
and	O
___	O
follow	O
up.	O
#	O
Elevated	O
troponins:	O
Likely	O
Type	O
II	O
NSTEMI	O
in	O
setting	O
of	O
acute	O
heart	O
failure,	O
worsening	O
CKD.	O
Patient	O
had	O
no	O
ischemic	O
changes	O
by	O
EKG.	O
She	O
complained	O
of	O
some	O
intermittent	O
atypical	O
chest	O
pain,	O
so	O
outpatient	O
cardiologist	O
may	O
consider	O
nuclear	O
stress	O
imaging.	O
Patient's	O
troponins	O
remained	O
stable	O
at	O
0.06.	O
#	O
Anemia:	O
Patient's	O
Hb	O
8.4	O
on	O
admission,	O
which	O
is	O
close	O
to	O
baseline.	O
Anemia	O
likely	O
secondary	O
to	O
CKD.	O
On	O
PO	O
iron	O
supplementation	O
and	O
Aranesp	O
as	O
outpatient.	O
Iron	O
supplementation	O
continued	O
while	O
inpatient.	O
Patient's	O
hemoglobin	O
remained	O
stable.	O
Transitional	O
Issues	O
======================	O
Discharge	O
weight:77.7kg	O
Medications	O
ADDED	O
during	O
this	O
hostpialization:	O
Sevelamer	O
1600mg	O
TID,	O
Torsemide	O
20mg	O
every	O
other	O
day	O
Medications	O
STOPPED	O
during	O
this	O
hospitalization:	O
Furosemide	O
40/60mg	O
daily,	O
Metoprolol	O
XL	O
50	O
daily.	O
-Patient's	O
creatinine	O
increased	O
from	O
5.2	O
on	O
admission	O
to	O
7.3	O
on	O
discharge.	O
Decision	O
was	O
made	O
not	O
to	O
begin	O
dialysis,	O
per	O
discussion	O
with	O
patient,	O
patient's	O
PCP	O
and	O
outpatient	O
nephrologist.	O
She	O
will	O
be	O
followed	O
very	O
closely	O
by	O
Dr.	O
___	O
as	O
outpatient.	O
-Patient	O
should	O
have	O
labs	O
drawn	O
for	O
CHEM	O
10	O
on	O
___	O
to	O
check	O
Creatinine	O
and	O
electrolytes.	O
-Patient	O
should	O
follow	O
a	O
low	O
sodium,	O
low	O
potassium	O
and	O
low	O
phosphorus	O
diet.	O
She	O
was	O
educated	O
about	O
this	O
diet	O
and	O
provided	O
with	O
reading	O
material	O
upon	O
discharge.	O
-Patient	O
has	O
new	O
diagnosis	O
of	O
mild	O
aortic	O
stenosis.	O
She	O
should	O
have	O
repeat	O
TTE	O
in	O
one	O
year.	O
-Patient	O
complained	O
of	O
atypical	O
chest	O
pain	O
on	O
admission,	O
worse	O
with	O
exertion.	O
___	O
consider	O
stress	O
MIBI	O
as	O
outpatient.	O
Code:	O
DNR/DNI	O
Contact:	O
granddaughter	O
___	O
___,	O
daughter	O
___	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q6H:PRN	O
L	O
arm,	O
shoulder	O
pain	O
2.	O
Sodium	O
Bicarbonate	O
1300	O
mg	O
PO	O
BID	O
3.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Cream	O
1	O
Appl	O
TP	O
BID	O
4.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
5.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
6.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
7.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
8.	O
Furosemide	O
40	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
9.	O
Furosemide	O
60	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
10.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
11.	O
Omeprazole	O
40	O
mg	O
PO	O
BID	O
12.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
13.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q6H:PRN	O
L	O
arm,	O
shoulder	O
pain	O
2.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
DAILY	O
5.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
6.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
7.	O
Omeprazole	O
40	O
mg	O
PO	O
BID	O
8.	O
Sodium	O
Bicarbonate	O
1300	O
mg	O
PO	O
BID	O
9.	O
Labetalol	O
200	O
mg	O
PO	O
TID	O
RX	O
*labetalol	O
200	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
10.	O
sevelamer	O
CARBONATE	O
1600	O
mg	O
PO	O
TID	O
W/MEALS	O
RX	O
*sevelamer	O
carbonate	O
[___]	O
800	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
TID	O
with	O
meals	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
11.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
12.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Cream	O
1	O
Appl	O
TP	O
BID	O
13.	O
Outpatient	O
Lab	O
Work	O
CHEM	O
10	O
585.4	O
Please	O
fax	O
results	O
to	O
Dr.	O
___	O
___	O
14.	O
Torsemide	O
20	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
RX	O
*torsemide	O
20	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
other	O
day	O
Disp	O
#*15	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
___:	O
Primary	O
Diagnosis:	O
1.	O
Acute	O
on	O
chronic	O
diastolic	O
heart	O
failure	O
2.	O
Acute	O
on	O
chronic	O
kidney	O
disease	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___	O
___.	O
You	O
were	O
admitted	O
with	O
shortness	O
of	O
breath.	O
You	O
were	O
found	O
to	O
have	O
extra	O
fluid	O
in	O
your	O
body	O
due	O
to	O
heart	O
failure,	O
which	O
was	O
causing	O
you	O
to	O
have	O
difficulty	O
breathing.	O
We	O
gave	O
you	O
medication	O
to	O
remove	O
the	O
fluid	O
and	O
your	O
breathing	O
improved.	O
During	O
this	O
admission	O
your	O
kidney	O
function	O
worsened.	O
You	O
were	O
seen	O
by	O
kidney	O
specialists	O
who	O
determined	O
that	O
you	O
do	O
not	O
need	O
to	O
begin	O
dialysis	O
at	O
this	O
time.	O
You	O
will	O
be	O
followed	O
closely	O
by	O
your	O
primary	O
care	O
doctor,	O
___	O
your	O
kidney	O
doctor,	O
___	O
as	O
an	O
outpatient.	O
You	O
should	O
follow	O
up	O
with	O
Dr.	O
___	O
Dr.	O
___	O
one	O
week	O
of	O
discharge	O
(see	O
appointments	O
below).	O
You	O
should	O
also	O
schedule	O
follow	O
up	O
with	O
cardiology,	O
for	O
your	O
heart	O
failure.	O
We	O
wish	O
you	O
all	O
the	O
best	O
in	O
your	O
recovery!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

